Enterovirus A, Human
-
Subject Areas on Research
- A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice.
- Antiviral effects of Retro-2cycl and Retro-2.1 against Enterovirus 71 in vitro and in vivo.
- BPIFB6 Regulates Secretory Pathway Trafficking and Enterovirus Replication.
- Complete genome sequencing and analysis of six enterovirus 71 strains with different clinical phenotypes.
- Construction and characterization of infectious cDNA clones of enterovirus 71 (EV71).
- Contribution of 3CD Region to the Virulence of Enterovirus 71.
- Determination of the cleavage site of enterovirus 71 VP0 and the effect of this cleavage on viral infectivity and assembly.
- Establishment of cell lines with increased susceptibility to EV71/CA16 by stable overexpression of SCARB2.
- High-yield production of recombinant virus-like particles of enterovirus 71 in Pichia pastoris and their protective efficacy against oral viral challenge in mice.
- IRES-targeting small molecule inhibits enterovirus 71 replication via allosteric stabilization of a ternary complex.
- Identification of a common epitope between enterovirus 71 and human MED25 proteins which may explain virus-associated neurological disease.
- Mast cells contribute to Enterovirus 71 infection-induced pulmonary edema in neonatal mice.
- MicroRNA-628-5p Facilitates Enterovirus 71 Infection by Suppressing TRAF3 Signaling.
- Pathogenesis Study of Enterovirus 71 Using a Novel Human SCARB2 Knock-In Mouse Model.
- Synonymous codon usage analysis of hand, foot and mouth disease viruses: A comparative study on coxsackievirus A6, A10, A16, and enterovirus 71 from 2008 to 2015.
- Type III interferon signaling restricts enterovirus 71 infection of goblet cells.